Epidemiological Characteristics, Transmission Dynamics, and Integrated Control Strategies of Chikungunya Fever

Authors

  • Haochuan Ding

DOI:

https://doi.org/10.61173/epvjx394

Keywords:

chikungunya fever, prevention, public health, molecular epidemiology, transmission dynamics

Abstract

Chikungunya fever (CHIKF) is a re-emerging mosquito-borne viral disease with an expanding global and regional footprint. This study investigates its epidemiological trends, molecular evolution, and control strategies, with a particular focus on recent developments in China. Drawing on data from 2010–2025, it integrates spatial, temporal, and genomic analyses to elucidate transmission dynamics and adaptive mutations. Globally, cyclical outbreaks occur every 3–5 years, driven primarily by the East/Central/South African (ECSA) lineage’s enhanced transmissibility via Aedes albopictus. In China, chikungunya has progressed from sporadic importations to limited local circulation, especially in Guangdong and Fujian provinces. Molecular evidence reveals ECSA-derived variants carrying adaptive mutations (E1:A226V, E2:L210Q) that confer improved vector adaptation. Persistent challenges—including misdiagnosis, fragmented surveillance systems, and inconsistent genomic monitoring—continue to hinder effective control. This study highlights the urgent need for integrated vector management, strengthened molecular surveillance, and regional cooperation to prevent endemic establishment and reduce chikungunya’s long-term public health and socioeconomic impacts.

References

M. J., & Cavalcanti, L. P. (2023). Epidemiology and Economic Burden of Chikungunya: A Systematic Literature Review. Tropical Medicine and Infectious Disease, 8(6). Khongwichit, S., Chansaenroj, J., Chirathaworn, C., &

Poovorawan, Y. (2021). Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries. Journal of Biomedical Science, 28(1), 84. https://doi.org/10.1186/s12929-021-00778-8 Krambrich, J., Mihalič, F., Gaunt, M. W., Bohlin, J., Hesson, J. C., Lundkvist, Å., de Lamballerie, X., Li, C.,

Shi, W., & Pettersson, J. H. O. (2024). The evolutionary and molecular history of a chikungunya virus outbreak lineage. PLOS Neglected Tropical Diseases, 18(7), e0012349. https://doi.org/10.1371/journal.pntd.0012349 Moreira, F. R. R., Menezes, M. T. d., Salgado-Benvindo, C., Whittaker, C., Cox, V., Chandradeva, N., Paula, H. H. S. d., Martins, A. F., Chagas, R. R. d., Brasil, R. D. V., Cândido, D. d. S., Herlinger, A. L., Ribeiro, M. d. O., Arruda, M. B., Alvarez, P., Tôrres, M. C. d. P., Dorigat-

ti, I., Brady, O., Voloch, C. M.,…Aguiar, R. S. (2023). Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015

and 2018. PLOS Neglected Tropical Diseases, 17(9), e0011536. https://doi.org/10.1371/journal.pntd.0011536 Schneider, M., Narciso-Abraham, M., Hadl, S., McMahon, R., Toepfer, S., Fuchs, U., Hochreiter, R., Bitzer, A., Kosulin, K., Larcher-Senn, J., Mader, R., Dubischar, K., Zoihsl, O., Jaramillo, J. C., Eder-Lingelbach, S., Buerger,

V., & Wressnigg, N. (2023). Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. (1474-547X (Electronic)). Shandhi, S. A.-O., Malaker, S. A.-O., Shahriar, M., &

Anjum, R. A.-O. (2025). Chikungunya virus: from genetic adaptation to pandemic risk and prevention. (2049-9361 (Print)). Thiberville, S.-D., Moyen, N., Dupuis-Maguiraga, L., Nougairede, A., Gould, E. A., Roques, P., & de Lam-

ballerie, X. (2013). Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Research, 99(3), 345–370. https://doi.org/https://doi. org/10.1016/j.antiviral.2013.06.009 Zhang, D., Qiu, Z., Hao, Y., Yuan, Y., Ma, W., Li, N., &

Xiao, P. (2025). Progress in the molecular epidemiology of chikungunya virus. Animals and Zoonoses, 1(2), 164–169. https://doi.org/https://doi.org/10.1016/j.azn.2025.01.003

Downloads

Published

2025-12-19